Cytokeratin Positivity in Myxopapillary Ependymoma
Author Information
Author(s): Hussein Sundus A, Sur Monalisa
Primary Institution: McMaster University
Hypothesis
Can myxopapillary ependymomas express cytokeratins, leading to potential misdiagnosis?
Conclusion
Myxopapillary ependymomas can express cytokeratins, which may lead to misdiagnosis as metastatic carcinoma.
Supporting Evidence
- Myxopapillary ependymomas are slow-growing gliomas that can be misdiagnosed due to their morphology.
- Cytokeratin positivity in myxopapillary ependymomas has been controversial, with few cases reported.
- Both cases in this study showed strong positivity for cytokeratin markers.
Takeaway
Some tumors called myxopapillary ependymomas can look like other types of cancer because they have similar features, so doctors need to be careful when diagnosing them.
Methodology
Two cases of myxopapillary ependymoma were examined for cytokeratin expression using immunohistochemical staining.
Potential Biases
Potential for misdiagnosis due to morphological similarities with other tumors.
Limitations
The study is based on only two cases, which may not represent the broader population of myxopapillary ependymomas.
Participant Demographics
Two female patients aged 46 and 72.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website